ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Evolving Standards of Care

COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

on: May 21, 2025In: Evolving Standards of Care
COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

The COCOON trial compared SOC with prophylactic management for treatment-related dermatologic events with amivantamab plus lazertinib. In this Q&A, Dr. Martin F. Dietrich explains the prophylactic regimen’s impact on effects of the skin, scalp, and nails. APP Alyson Singer offers best practices for patient education. Read more

Determining the Most Effective Chemotherapy Regimen in Patients With Advanced KRAS-Mutated NSCLC: the NVALT22 study

Sophie M. Ernst, MD
+more
on: March 09, 2022In: Evolving Standards of Care
Determining the Most Effective Chemotherapy Regimen in Patients With Advanced KRAS-Mutated NSCLC: the NVALT22 study

Study tests combination of taxanes with an angiogenesis inhibitor in search for better outcomes for patients with advanced KRAS-mutated NSCLC. Read more

Novel Targets and Therapies: KEAP1- and NFE2L2-Mutant Squamous Cell Lung Cancer

Paul Paik, MD
+more
on: March 09, 2022In: Evolving Standards of Care
Novel Targets and Therapies: KEAP1- and NFE2L2-Mutant Squamous Cell Lung Cancer

During an interview with ILCN, Drs. Paul Paik and Jonathan Reiss discuss the implications of KEAP1 and NFE2L2 mutations in NSCLC. Read more

Role of Liquid Biopsy in the Clinic Growing

Leah Lawrence
on: March 09, 2022In: Evolving Standards of Care, Screening/ED
Role of Liquid Biopsy in the Clinic Growing

Lung cancer specialists are slowly being faced with the challenge of how to balance the benefits of next-generation tumor tissue testing against those of liquid biopsy in the clinic. During […] Read more

Multidisciplinary Tumor Boards: Six Eyes See More than Two

Mihaela Aldea, MD, PhD
+more
on: February 23, 2022In: Evolving Standards of Care
Multidisciplinary Tumor Boards: Six Eyes See More than Two

See how specialists in France use MTBs to develop the most beneficial treatment strategies for patients and to decrease inequity in cancer care. Read more

Unplanned Hospital Care in Patients With NSCLC

Manan P. Shah, MD
+more
on: February 23, 2022In: Evolving Standards of Care
Unplanned Hospital Care in Patients With NSCLC

Study findings suggest that a significant number of unplanned hospital visits for patients with lung cancer might be avoidable. Read more

Predicting Early Weight Loss in Radiotherapy

Dirk De Ruysscher, MD, PhD
on: February 23, 2022In: Evolving Standards of Care
Predicting Early Weight Loss in Radiotherapy

Study shows emerging techniques may improve prognostic and predictive models in identifying patients at risk for early weight loss. Read more

In Brief for February 9, 2022

John Austin
on: February 09, 2022In: Evolving Standards of Care, Meeting News, Names & News
In Brief for February 9, 2022

TTLC goes virtual. Positive results reported for pembrolizumab. GO2 Foundation names Chief of Healthcare Delivery. Read more

The Art and Science of Patient–Doctor Communication

Corey J. Langer, MD, FACP
+more
on: January 26, 2022In: Evolving Standards of Care, Patient Advocacy
The Art and Science of Patient–Doctor Communication

When facing a grave illness, especially for the first time, many people are worried, frightened, and overwhelmed. They may have difficulty focusing their attention on daily tasks and experience skewed […] Read more

Multifaceted Initiative Launches Aimed at Reducing Lung Cancer Deaths 25% by 2030

Raymond U. Osarogiagbon, MBBS, FACP
on: December 22, 2021In: Evolving Standards of Care
Multifaceted Initiative Launches Aimed at Reducing Lung Cancer Deaths 25% by 2030

The Baptist Cancer Center in Memphis, Tennessee, has launched a new initiative that comprises seven components that will address prevention, diagnosis, and treatment of lung cancer through smoking cessation, low-dose […] Read more

COVID-19 and Lung Cancer

Lauren C. Shapiro
+more
on: December 10, 2021In: Evolving Standards of Care
COVID-19 and Lung Cancer

Data from multiple groups1,2 have shown the significant impact of COVID-19 infection among patients with malignancies, leading to high overall morbidity and mortality; this includes our own institution,3 which saw […] Read more

«‹10111213141516›»

SEARCH ILCN

Archives

PROVIDER RESOURCES

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

INDUSTRY SUPPORTED


COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

INDUSTRY SUPPORTED

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy